JENBURKT PHARMACEUTICALS
|
JENBURKT PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹137 Cr | ₹124 Cr | ₹109 Cr | ₹119 Cr | ₹123 Cr |
Sales | ₹136 Cr | ₹124 Cr | ₹109 Cr | ₹118 Cr | ₹122 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹0.61 Cr | ₹0.25 Cr | ₹0.43 Cr | ₹0.85 Cr | ₹0.59 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹137 Cr | ₹124 Cr | ₹109 Cr | ₹119 Cr | ₹123 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹1.34 Cr | ₹-2.29 Cr | ₹3.18 Cr | ₹-0.49 Cr | ₹-2.49 Cr |
Raw Material Consumed | ₹27 Cr | ₹30 Cr | ₹25 Cr | ₹31 Cr | ₹36 Cr |
Opening Raw Materials | ₹1.73 Cr | ₹1.69 Cr | ₹2.16 Cr | ₹1.62 Cr | ₹1.03 Cr |
Purchases Raw Materials | ₹6.44 Cr | ₹7.79 Cr | ₹3.94 Cr | ₹7.19 Cr | ₹9.30 Cr |
Closing Raw Materials | ₹1.51 Cr | ₹1.73 Cr | ₹1.69 Cr | ₹2.16 Cr | ₹1.62 Cr |
Other Direct Purchases / Brought in cost | ₹21 Cr | ₹22 Cr | ₹20 Cr | ₹24 Cr | ₹27 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹0.76 Cr | ₹0.61 Cr | ₹0.50 Cr | ₹0.59 Cr | ₹0.59 Cr |
Electricity & Power | ₹0.76 Cr | ₹0.61 Cr | ₹0.50 Cr | ₹0.59 Cr | ₹0.59 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹39 Cr | ₹36 Cr | ₹32 Cr | ₹37 Cr | ₹31 Cr |
Salaries, Wages & Bonus | ₹35 Cr | ₹33 Cr | ₹29 Cr | ₹31 Cr | ₹28 Cr |
Contributions to EPF & Pension Funds | ₹3.08 Cr | ₹3.25 Cr | ₹3.60 Cr | ₹5.00 Cr | ₹3.02 Cr |
Workmen and Staff Welfare Expenses | ₹0.27 Cr | ₹0.27 Cr | ₹0.16 Cr | ₹0.23 Cr | ₹0.14 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹6.49 Cr | ₹5.70 Cr | ₹3.70 Cr | ₹4.45 Cr | ₹4.76 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | ₹4.46 Cr | ₹3.99 Cr | ₹2.37 Cr | ₹3.00 Cr | ₹3.13 Cr |
Other Mfg Exp | ₹2.03 Cr | ₹1.71 Cr | ₹1.33 Cr | ₹1.44 Cr | ₹1.63 Cr |
General and Administration Expenses | ₹15 Cr | ₹6.46 Cr | ₹7.12 Cr | ₹8.27 Cr | ₹10 Cr |
Rent , Rates & Taxes | ₹0.17 Cr | ₹0.19 Cr | ₹0.17 Cr | ₹0.18 Cr | ₹0.67 Cr |
Insurance | ₹0.32 Cr | ₹0.27 Cr | ₹0.27 Cr | ₹0.19 Cr | ₹0.29 Cr |
Printing and stationery | ₹1.06 Cr | ₹0.67 Cr | ₹0.22 Cr | ₹0.78 Cr | ₹1.84 Cr |
Professional and legal fees | ₹1.47 Cr | ₹1.21 Cr | ₹2.79 Cr | ₹1.92 Cr | ₹2.02 Cr |
Traveling and conveyance | ₹0.60 Cr | ₹1.74 Cr | ₹1.29 Cr | ₹2.50 Cr | ₹2.64 Cr |
Other Administration | ₹12 Cr | ₹2.40 Cr | ₹2.38 Cr | ₹2.71 Cr | ₹3.03 Cr |
Selling and Distribution Expenses | ₹16 Cr | ₹20 Cr | ₹17 Cr | ₹19 Cr | ₹17 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | ₹4.38 Cr | ₹3.38 Cr | ₹3.55 Cr | ₹3.02 Cr | ₹3.42 Cr |
Freight and Forwarding | ₹2.65 Cr | ₹2.51 Cr | ₹1.50 Cr | ₹1.79 Cr | ₹1.64 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹9.10 Cr | ₹14 Cr | ₹12 Cr | ₹14 Cr | ₹12 Cr |
Miscellaneous Expenses | ₹0.50 Cr | ₹0.01 Cr | ₹0.95 Cr | ₹0.54 Cr | ₹0.35 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | ₹0.04 Cr |
Losson foreign exchange fluctuations | - | - | - | - | ₹0.01 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.50 Cr | ₹0.01 Cr | ₹0.95 Cr | ₹0.54 Cr | ₹0.31 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹106 Cr | ₹97 Cr | ₹89 Cr | ₹99 Cr | ₹98 Cr |
Operating Profit (Excl OI) | ₹30 Cr | ₹27 Cr | ₹20 Cr | ₹20 Cr | ₹25 Cr |
Other Income | ₹5.12 Cr | ₹4.95 Cr | ₹4.31 Cr | ₹4.22 Cr | ₹3.45 Cr |
Interest Received | ₹4.02 Cr | ₹4.37 Cr | ₹4.05 Cr | ₹3.64 Cr | ₹3.21 Cr |
Dividend Received | ₹0.05 Cr | ₹0.03 Cr | ₹0.02 Cr | ₹0.05 Cr | ₹0.23 Cr |
Profit on sale of Fixed Assets | - | ₹0.18 Cr | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹0.08 Cr | ₹0.08 Cr | - | - | ₹0.00 Cr |
Foreign Exchange Gains | ₹0.76 Cr | ₹0.25 Cr | ₹0.22 Cr | ₹0.37 Cr | - |
Others | ₹0.22 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.17 Cr | ₹0.01 Cr |
Operating Profit | ₹35 Cr | ₹32 Cr | ₹24 Cr | ₹24 Cr | ₹28 Cr |
Interest | ₹0.37 Cr | ₹0.43 Cr | ₹0.47 Cr | ₹0.53 Cr | ₹0.39 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.07 Cr | ₹0.09 Cr | ₹0.05 Cr | ₹0.03 Cr | ₹0.03 Cr |
Other Interest | ₹0.30 Cr | ₹0.35 Cr | ₹0.42 Cr | ₹0.49 Cr | ₹0.35 Cr |
PBDT | ₹35 Cr | ₹32 Cr | ₹24 Cr | ₹23 Cr | ₹28 Cr |
Depreciation | ₹2.26 Cr | ₹1.90 Cr | ₹2.04 Cr | ₹2.30 Cr | ₹1.35 Cr |
Profit Before Taxation & Exceptional Items | ₹33 Cr | ₹30 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹33 Cr | ₹30 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr |
Provision for Tax | ₹8.26 Cr | ₹7.57 Cr | ₹5.14 Cr | ₹6.27 Cr | ₹6.84 Cr |
Current Income Tax | ₹8.56 Cr | ₹7.35 Cr | ₹5.45 Cr | ₹5.76 Cr | ₹7.52 Cr |
Deferred Tax | ₹-0.23 Cr | ₹0.30 Cr | ₹-0.39 Cr | ₹0.37 Cr | ₹-0.31 Cr |
Other taxes | ₹-0.08 Cr | ₹-0.07 Cr | ₹0.09 Cr | ₹0.14 Cr | ₹-0.38 Cr |
Profit After Tax | ₹25 Cr | ₹22 Cr | ₹17 Cr | ₹15 Cr | ₹20 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹109 Cr | ₹91 Cr | ₹74 Cr | ₹69 Cr | ₹53 Cr |
Appropriations | ₹133 Cr | ₹113 Cr | ₹91 Cr | ₹84 Cr | ₹73 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | ₹1.73 Cr | ₹0.57 Cr |
Other Appropriation | ₹20 Cr | ₹4.68 Cr | - | ₹8.15 Cr | ₹3.09 Cr |
Equity Dividend % | ₹144.00 | ₹120.00 | ₹102.00 | ₹81.00 | ₹102.00 |
Earnings Per Share | ₹55.76 | ₹48.58 | ₹35.96 | ₹32.40 | ₹43.14 |
Adjusted EPS | ₹55.76 | ₹48.58 | ₹35.96 | ₹32.40 | ₹43.14 |
Compare Income Statement of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹553.8 Cr | 0.4% | -4.1% | 61.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,037.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,854.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,746.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 0.4% |
-4.1% |
61.1% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses